Drug intelligence / Profile preview

sodium chloride + magnesium chloride + sodium gluconate + potassium chloride

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Small Molecules
Administration
Intravenous
01

Overview

sodium chloride + magnesium chloride + sodium gluconate + potassium chloride is a **multi-electrolyte crystalloid intravenous solution** intended to provide water and physiologic electrolytes for hydration and correction of fluid and electrolyte deficits. It is best understood as a **specific ingredient subset** found within balanced electrolyte solutions related to the Plasma-Lyte family, but the exact four-ingredient name does **not uniquely identify a single marketed Baxter product label** because publicly available Baxter and DailyMed labels for Multiple Electrolytes Injection, Type 1, USP and PLASMA-LYTE A/148 also include **sodium acetate** in addition to these four components. Mechanistically, this combination has no single discrete receptor or enzyme target; it acts by expanding the extracellular fluid compartment, replenishing sodium, potassium, magnesium, and chloride, and providing an alkalinizing buffer contribution through metabolism of gluconate. Clinically, such balanced electrolyte solutions are used as a source of water and electrolytes and as an alkalinizing agent, with related products also used for dehydration and electrolyte imbalance management and, in some formulations, irrigation or rinsing applications.

Other names
sodium chloride + magnesium chloride + sodium gluconate + potassium chloride

Beyond the preview

Go deeper on sodium chloride + magnesium chloride + sodium gluconate + potassium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium chloride + magnesium chloride + sodium gluconate + potassium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call